Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5-((1-methyl-3-indolyl)carbonyl)-4,5,6,7-tetrahydro-1h-benzimidazol
2. Methanone, (1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-1h-benzimidazol-5-yl)-, Monohydrochloride, (r)-
3. Nasea
4. Ramosetron
5. Ym 060
6. Ym-060
7. Ym060
1. 132907-72-3
2. Ramosetron Hcl
3. Nasea
4. Irribow
5. Ym060
6. Ym-060
7. (r)-(1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-1h-benzo[d]imidazol-6-yl)methanone Hydrochloride
8. Ym 060
9. Ramosetron.hcl
10. Ramosetron (hydrochloride)
11. (r)-(-)-ramosetron Hydrochloride
12. 9551lhd87e
13. Dsstox_cid_1223
14. (1-methylindol-3-yl)-[(5r)-4,5,6,7-tetrahydro-3h-benzimidazol-5-yl]methanone;hydrochloride
15. (r)-5-((1-methyl-3-indolyl)carbonyl)-4,5,6,7-tetrahydro-1h-benzimidazole Hydrochloride
16. Dsstox_rid_76021
17. Dsstox_gsid_21223
18. Ramosetron Hydrochloride (jan)
19. Ramosetron Hydrochloride [jan]
20. Ccris 7704
21. Cas-132907-72-3
22. (r)-(1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-
23. Unii-9551lhd87e
24. (r)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1h-benzimidazole Hydrochloride
25. Nasea Od
26. (-)-(r)-5-((1-methyl-1h-indol-3-yl)carbonyl)-4,5,6,7-tetrahydro-1h-benzimidazole Monohydrochloride
27. (-)-(r)-5-[(1-methyl-1h-indol-3-yl)carbonyl]-4,5,6,7-tetrahydro-1h-benzimidazole Monohydrochloride
28. Methanone, (1-methyl-1h-indol-3-yl)((6r)-4,5,6,7-tetrahydro-1h-benzimidazol-6-yl)-, Hydrochloride (1:1)
29. Methanone, (1-methyl-1h-indol-3-yl)[(6r)-4,5,6,7-tetrahydro-1h-benzimidazol-6-yl]-, Hydrochloride (1:1)
30. Irribow (tn)
31. Nasea (tn)
32. Ramosetron Hydrochloride,(s)
33. Methanone, (1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-1h-benzimidazol-5-yl)-, Monohydrochloride, (r)-
34. Schembl447023
35. Chembl3181841
36. Dtxsid3021223
37. Chebi:32088
38. Act02590
39. Amy15420
40. Hy-b0595
41. Ym060ym-060
42. Tox21_112441
43. Mfcd19441800
44. Ramosetron Hydrochloride [mi]
45. S3723
46. Akos015895434
47. Tox21_112441_1
48. Ccg-267653
49. Ks-1311
50. Ramosetron Hydrochloride [mart.]
51. Ncgc00167437-02
52. Ramosetron Hydrochloride [who-dd]
53. (1-methyl-1h-indol-3-yl)[(5r)-4,5,6,7-tetrahydro-1h-benzimidazol-5-yl]methanone Hydrochloride
54. (1-methyl-1h-indol-3-yl)[(6r)-4,5,6,7-tetrahydro-1h-benzimidazol-6-yl]methanone Hydrochloride
55. Methanone, (1-methyl-1h-indol-3-yl)((5r)-4,5,6,7-tetrahydro-1h-benzimidazol-5-yl)-, Monohydrochloride
56. R-145
57. D02016
58. 907r723
59. A806524
60. Q27271742
61. (r)-(-)-5-[(1-methylindol-3-yl)carbonyl]-4,5,6,7-tetrahydrobenzimidazole Hydrochloride
62. (1-methylindol-3-yl)-[(5r)-4,5,6,7-tetrahydro-3h-benzimidazol-5-yl]methanone;hydrochloride.
63. (r)-(1-methyl-1h-indol-3-yl)(4,5,6,7-tetrahydro-1h-benzo[d]imidazol-5-yl)methanone Hydrochloride
| Molecular Weight | 315.8 g/mol |
|---|---|
| Molecular Formula | C17H18ClN3O |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 315.1138399 g/mol |
| Monoisotopic Mass | 315.1138399 g/mol |
| Topological Polar Surface Area | 50.7 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 413 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Market Place
ABOUT THIS PAGE
A Ramosetron HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ramosetron HCl, including repackagers and relabelers. The FDA regulates Ramosetron HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ramosetron HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ramosetron HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ramosetron HCl supplier is an individual or a company that provides Ramosetron HCl active pharmaceutical ingredient (API) or Ramosetron HCl finished formulations upon request. The Ramosetron HCl suppliers may include Ramosetron HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Ramosetron HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ramosetron HCl Drug Master File in Korea (Ramosetron HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ramosetron HCl. The MFDS reviews the Ramosetron HCl KDMF as part of the drug registration process and uses the information provided in the Ramosetron HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ramosetron HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ramosetron HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ramosetron HCl suppliers with KDMF on PharmaCompass.
Ramosetron HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ramosetron HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ramosetron HCl GMP manufacturer or Ramosetron HCl GMP API supplier for your needs.
A Ramosetron HCl CoA (Certificate of Analysis) is a formal document that attests to Ramosetron HCl's compliance with Ramosetron HCl specifications and serves as a tool for batch-level quality control.
Ramosetron HCl CoA mostly includes findings from lab analyses of a specific batch. For each Ramosetron HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ramosetron HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Ramosetron HCl EP), Ramosetron HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ramosetron HCl USP).
LOOKING FOR A SUPPLIER?
